211 related articles for article (PubMed ID: 27318215)
1. In vivo imaging of brain glutamate defects in a knock-in mouse model of Huntington's disease.
Pépin J; Francelle L; Carrillo-de Sauvage MA; de Longprez L; Gipchtein P; Cambon K; Valette J; Brouillet E; Flament J
Neuroimage; 2016 Oct; 139():53-64. PubMed ID: 27318215
[TBL] [Abstract][Full Text] [Related]
2. In Vivo Multidimensional Brain Imaging in Huntington's Disease Animal Models.
Flament J; Hantraye P; Valette J
Methods Mol Biol; 2018; 1780():285-301. PubMed ID: 29856025
[TBL] [Abstract][Full Text] [Related]
3. Complementarity of gluCEST and
Pépin J; de Longprez L; Trovero F; Brouillet E; Valette J; Flament J
NMR Biomed; 2020 Jul; 33(7):e4301. PubMed ID: 32198958
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal multimodal MRI characterization of a knock-in mouse model of Huntington's disease reveals early gray and white matter alterations.
Pérot JB; Célestine M; Palombo M; Dhenain M; Humbert S; Brouillet E; Flament J
Hum Mol Genet; 2022 Oct; 31(21):3581-3596. PubMed ID: 35147158
[TBL] [Abstract][Full Text] [Related]
5. Characterization of Behavioral, Neuropathological, Brain Metabolic and Key Molecular Changes in zQ175 Knock-In Mouse Model of Huntington's Disease.
Peng Q; Wu B; Jiang M; Jin J; Hou Z; Zheng J; Zhang J; Duan W
PLoS One; 2016; 11(2):e0148839. PubMed ID: 26859386
[TBL] [Abstract][Full Text] [Related]
6. Similar Progression of Morphological and Metabolic Phenotype in R6/2 Mice with Different CAG Repeats Revealed by In Vivo Magnetic Resonance Imaging and Spectroscopy.
Sawiak SJ; Wood NI; Morton AJ
J Huntingtons Dis; 2016 Oct; 5(3):271-283. PubMed ID: 27662335
[TBL] [Abstract][Full Text] [Related]
7. Characterization of neurophysiological and behavioral changes, MRI brain volumetry and 1H MRS in zQ175 knock-in mouse model of Huntington's disease.
Heikkinen T; Lehtimäki K; Vartiainen N; Puoliväli J; Hendricks SJ; Glaser JR; Bradaia A; Wadel K; Touller C; Kontkanen O; Yrjänheikki JM; Buisson B; Howland D; Beaumont V; Munoz-Sanjuan I; Park LC
PLoS One; 2012; 7(12):e50717. PubMed ID: 23284644
[TBL] [Abstract][Full Text] [Related]
8. Mass Spectrometry Analysis of Wild-Type and Knock-in Q140/Q140 Huntington's Disease Mouse Brains Reveals Changes in Glycerophospholipids Including Alterations in Phosphatidic Acid and Lyso-Phosphatidic Acid.
Vodicka P; Mo S; Tousley A; Green KM; Sapp E; Iuliano M; Sadri-Vakili G; Shaffer SA; Aronin N; DiFiglia M; Kegel-Gleason KB
J Huntingtons Dis; 2015; 4(2):187-201. PubMed ID: 26397899
[TBL] [Abstract][Full Text] [Related]
9. Early white matter abnormalities, progressive brain pathology and motor deficits in a novel knock-in mouse model of Huntington's disease.
Jin J; Peng Q; Hou Z; Jiang M; Wang X; Langseth AJ; Tao M; Barker PB; Mori S; Bergles DE; Ross CA; Detloff PJ; Zhang J; Duan W
Hum Mol Genet; 2015 May; 24(9):2508-27. PubMed ID: 25609071
[TBL] [Abstract][Full Text] [Related]
10. Mapping the alterations in glutamate with GluCEST MRI in a mouse model of dopamine deficiency.
Bagga P; Crescenzi R; Krishnamoorthy G; Verma G; Nanga RP; Reddy D; Greenberg J; Detre JA; Hariharan H; Reddy R
J Neurochem; 2016 Nov; 139(3):432-439. PubMed ID: 27529288
[TBL] [Abstract][Full Text] [Related]
11. Brain metabolite alterations and cognitive dysfunction in early Huntington's disease.
Unschuld PG; Edden RA; Carass A; Liu X; Shanahan M; Wang X; Oishi K; Brandt J; Bassett SS; Redgrave GW; Margolis RL; van Zijl PC; Barker PB; Ross CA
Mov Disord; 2012 Jun; 27(7):895-902. PubMed ID: 22649062
[TBL] [Abstract][Full Text] [Related]
12. Increased brain tissue sodium concentration in Huntington's Disease - a sodium imaging study at 4 T.
Reetz K; Romanzetti S; Dogan I; Saß C; Werner CJ; Schiefer J; Schulz JB; Shah NJ
Neuroimage; 2012 Oct; 63(1):517-24. PubMed ID: 22796981
[TBL] [Abstract][Full Text] [Related]
13. Selective reduction of striatal mature BDNF without induction of proBDNF in the zQ175 mouse model of Huntington's disease.
Ma Q; Yang J; Li T; Milner TA; Hempstead BL
Neurobiol Dis; 2015 Oct; 82():466-477. PubMed ID: 26282324
[TBL] [Abstract][Full Text] [Related]
14. Early and brain region-specific decrease of de novo cholesterol biosynthesis in Huntington's disease: A cross-validation study in Q175 knock-in mice.
Shankaran M; Di Paolo E; Leoni V; Caccia C; Ferrari Bardile C; Mohammed H; Di Donato S; Kwak S; Marchionini D; Turner S; Cattaneo E; Valenza M
Neurobiol Dis; 2017 Feb; 98():66-76. PubMed ID: 27913290
[TBL] [Abstract][Full Text] [Related]
15. Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's disease.
Dowie MJ; Bradshaw HB; Howard ML; Nicholson LF; Faull RL; Hannan AJ; Glass M
Neuroscience; 2009 Sep; 163(1):456-65. PubMed ID: 19524019
[TBL] [Abstract][Full Text] [Related]
16. Novel BAC Mouse Model of Huntington's Disease with 225 CAG Repeats Exhibits an Early Widespread and Stable Degenerative Phenotype.
Wegrzynowicz M; Bichell TJ; Soares BD; Loth MK; McGlothan JS; Mori S; Alikhan FS; Hua K; Coughlin JM; Holt HK; Jetter CS; Pomper MG; Osmand AP; Guilarte TR; Bowman AB
J Huntingtons Dis; 2015; 4(1):17-36. PubMed ID: 26333255
[TBL] [Abstract][Full Text] [Related]
17. Clinical correlation of striatal 1H MRS changes in Huntington's disease.
Sánchez-Pernaute R; García-Segura JM; del Barrio Alba A; Viaño J; de Yébenes JG
Neurology; 1999 Sep; 53(4):806-12. PubMed ID: 10489045
[TBL] [Abstract][Full Text] [Related]
18. Age-dependent and tissue-specific CAG repeat instability occurs in mouse knock-in for a mutant Huntington's disease gene.
Ishiguro H; Yamada K; Sawada H; Nishii K; Ichino N; Sawada M; Kurosawa Y; Matsushita N; Kobayashi K; Goto J; Hashida H; Masuda N; Kanazawa I; Nagatsu T
J Neurosci Res; 2001 Aug; 65(4):289-97. PubMed ID: 11494364
[TBL] [Abstract][Full Text] [Related]
19. Cerebral mapping of glutamate using chemical exchange saturation transfer imaging in a rat model of stress-induced sleep disturbance at 7.0T.
Lee DH; Woo CW; Kwon JI; Chae YJ; Ham SJ; Suh JY; Kim ST; Kim JK; Kim KW; Woo DC; Lee DW
J Magn Reson Imaging; 2019 Dec; 50(6):1866-1872. PubMed ID: 31033089
[TBL] [Abstract][Full Text] [Related]
20. Neurochemical correlates of caudate atrophy in Huntington's disease.
Padowski JM; Weaver KE; Richards TL; Laurino MY; Samii A; Aylward EH; Conley KE
Mov Disord; 2014 Mar; 29(3):327-35. PubMed ID: 24442623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
